INTRODUCTIONBioresorbable scaffolds have been heralded as the latest revolution in the field of percutaneous coronary intervention (PCI) . Unlike permanent metallic drug‐eluting stents (DES), bioresorbable scaffolds are designed to provide temporary structural integrity before being resorbed completely within the vessel. The transient presence of the scaffold offers a potential solution to the drawbacks of metallic DES; these drawbacks include hypersensitivity reactions, endothelial dysfunction, late stent thrombosis (ST), and preclusion of future surgical revascularization at the same lesion . With rapid technological advancement, cardiac multislice computed tomography (MSCT) angiography is currently considered to be an established technique for noninvasive evaluation of the coronary lumen and coronary plaques . However, MSCT assessment of a previously stented coronary artery is limited because of metal artifacts. Because of its radiolucent, polylactide backbone, the NeoVas scaffold does not affect computed tomography image interpretation, and MSCT can be used to assess changes in the lumen and vessels after its implantation.The angiographic, intravascular ultrasonography (IVUS), and optical coherence tomography (OCT) outcomes of this study were previously reported at the 6 months follow‐up . However, the clinical outcomes of the NeoVas scaffold for patients with single de novo lesions and plaque and lumen evolution at the 1 year follow‐up
Catheterization and Cardiovascular Interventions – Wiley
Published: Jan 15, 2018
Keywords: ; ; ;
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera